Viimased lisandused - Macular Telangiectasis
|
MacTel with foveal atrophy in both eyesvaatamisi: 10062 year old female with 20/50 OD, 20/40 OS.veebr 18, 2026
|
|
MacTel with foveal atrophy in both eyesvaatamisi: 7262 year old female with 20/50 OD, 20/40 OS.veebr 18, 2026
|
|
MacTel with foveal atrophy in both eyesvaatamisi: 9962 year old female with 20/50 OD, 20/40 OS.veebr 18, 2026
|
|
MacTel with foveal atrophy in both eyesvaatamisi: 10762 year old female with 20/50 OD, 20/40 OS.veebr 18, 2026
|
|
MacTel with foveal atrophy in both eyesvaatamisi: 9662 year old female with 20/50 OD, 20/40 OS.veebr 18, 2026
|
|
MacTel with foveal atrophy in both eyesvaatamisi: 10162 year old female with 20/50 OD, 20/40 OS.veebr 18, 2026
|
|
MacTel with foveal atrophy in both eyesvaatamisi: 12362 year old female with 20/50 OD, 20/40 OS.veebr 18, 2026
|
|
MacTel with foveal atrophy in both eyesvaatamisi: 8562 year old female with 20/50 OD, 20/40 OS.veebr 18, 2026
|
|
MacTel with foveal atrophy in both eyesvaatamisi: 9162 year old female with 20/50 OD, 20/40 OS.veebr 18, 2026
|
|
MacTel with foveal atrophy in both eyesvaatamisi: 9062 year old female with 20/50 OD, 20/40 OS.veebr 18, 2026
|
|
MacTel with foveal atrophy in both eyesvaatamisi: 9662 year old female with 20/50 OD, 20/40 OS.veebr 18, 2026
|
|
MacTel with foveal atrophy in both eyesvaatamisi: 9462 year old female with 20/50 OD, 20/40 OS.veebr 18, 2026
|
|
MacTel with foveal atrophy in both eyesvaatamisi: 10362 year old female with 20/50 OD, 20/40 OS.veebr 18, 2026
|
|
MacTel with foveal atrophy in both eyesvaatamisi: 8862 year old female with 20/50 OD, 20/40 OS.veebr 18, 2026
|
|
MacTel with foveal atrophy in both eyesvaatamisi: 11562 year old female with 20/50 OD, 20/40 OS.veebr 18, 2026
|
|
Macular Telangetasia MacTel - Nonproliferativevaatamisi: 18160 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSsept 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevaatamisi: 17760 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSsept 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevaatamisi: 19460 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSsept 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevaatamisi: 19060 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSsept 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevaatamisi: 13360 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSsept 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevaatamisi: 16460 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSsept 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevaatamisi: 16960 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSsept 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevaatamisi: 18460 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSsept 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevaatamisi: 14660 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSsept 17, 2024
|
|
Macular Telangetasia MacTel - Nonproliferativevaatamisi: 17160 year old non-diabetic female with gradual vision loss for 20 years. VA 20/80 OD, 20/63 OSsept 17, 2024
|
|
Macular telangiectasia - images from 10 years later - crystals vaatamisi: 42975 year old man with MacTel and a lot of crystals VA 20/63 OD, 20/50 OS.apr 30, 2023
|
|
Macular telangiectasia - images from 10 years later - crystals vaatamisi: 47075 year old man with MacTel and a lot of crystals VA 20/63 OD, 20/50 OS.apr 30, 2023
|
|
Macular telangiectasia - images from 10 years later - crystals vaatamisi: 45675 year old man with MacTel and a lot of crystals VA 20/63 OD, 20/50 OS.apr 30, 2023
|
|
Macular telangiectasia - images from 10 years later - crystals vaatamisi: 31275 year old man with MacTel and a lot of crystals VA 20/63 OD, 20/50 OS.apr 30, 2023
|
|
Macular telangiectasia - images from 10 years later - crystals vaatamisi: 24575 year old man with MacTel and a lot of crystals VA 20/63 OD, 20/50 OS.apr 30, 2023
|
|
Macular telangiectasia - images from 10 years later - crystals vaatamisi: 28275 year old man with MacTel and a lot of crystals VA 20/63 OD, 20/50 OS.apr 30, 2023
|
|
Macular telangiectasia - images from 10 years later - crystals vaatamisi: 29575 year old man with MacTel and a lot of crystals VA 20/63 OD, 20/50 OS.apr 30, 2023
|
|
Macular telangiectasia - images from 10 years later - crystals vaatamisi: 27475 year old man with MacTel and a lot of crystals VA 20/63 OD, 20/50 OS.apr 30, 2023
|
|
Macular telangiectasia - images from 10 years later - crystals vaatamisi: 26275 year old man with MacTel and a lot of crystals VA 20/63 OD, 20/50 OS.apr 30, 2023
|
|
Macular telangiectasia - images from 10 years later - crystals vaatamisi: 27875 year old man with MacTel and a lot of crystals VA 20/63 OD, 20/50 OS.apr 30, 2023
|
|
Stage V (neovascular) Macular Telangiectasia - Fluoresceinvaatamisi: 32367 year old female with vision in only the left eye. She has mild CNVM which is treated with Avastin and does well over several years.aug 16, 2022
|
|
Stage V (neovascular) Macular Telangiectasia - Fluoresceinvaatamisi: 30667 year old female with vision in only the left eye. She has mild CNVM which is treated with Avastin and does well over several years.aug 16, 2022
|
|
Stage V (neovascular) Macular Telangiectasia - Fluoresceinvaatamisi: 30367 year old female with vision in only the left eye. She has mild CNVM which is treated with Avastin and does well over several years.aug 16, 2022
|
|
Stage V (neovascular) Macular Telangiectasia - Fluoresceinvaatamisi: 29167 year old female with vision in only the left eye. She has mild CNVM which is treated with Avastin and does well over several years.aug 16, 2022
|
|
Stage V (neovascular) Macular Telangiectasia - Fluoresceinvaatamisi: 30867 year old female with vision in only the left eye. She has mild CNVM which is treated with Avastin and does well over several years.aug 16, 2022
|
|
Stage V (neovascular) Macular Telangiectasia - Fluoresceinvaatamisi: 31167 year old female with vision in only the left eye. She has mild CNVM which is treated with Avastin and does well over several years.aug 16, 2022
|
|
Stage V (neovascular) Macular Telangiectasia - Fluoresceinvaatamisi: 28567 year old female with vision in only the left eye. She has mild CNVM which is treated with Avastin and does well over several years.aug 16, 2022
|
|
Stage V (neovascular) Macular Telangiectasia - Fluoresceinvaatamisi: 29367 year old female with vision in only the left eye. She has mild CNVM which is treated with Avastin and does well over several years.aug 16, 2022
|
|
Stage V (neovascular) Macular Telangiectasia - Fluoresceinvaatamisi: 32467 year old female with vision in only the left eye. She has mild CNVM which is treated with Avastin and does well over several years.aug 16, 2022
|
|
Stage V (neovascular) Macular Telangiectasia - Fluoresceinvaatamisi: 27767 year old female with vision in only the left eye. She has mild CNVM which is treated with Avastin and does well over several years.aug 16, 2022
|
|
Stage V (neovascular) Macular Telangiectasia - Fluoresceinvaatamisi: 30867 year old female with vision in only the left eye. She has mild CNVM which is treated with Avastin and does well over several years.aug 16, 2022
|
|
Stage V (neovascular) Macular Telangiectasia - Fluoresceinvaatamisi: 26267 year old female with vision in only the left eye. She has mild CNVM which is treated with Avastin and does well over several years.aug 16, 2022
|
|
Stage V (neovascular) Macular Telangiectasia - Fluoresceinvaatamisi: 25667 year old female with vision in only the left eye. She has mild CNVM which is treated with Avastin and does well over several years.aug 16, 2022
|
|
Stage V (neovascular) Macular Telangiectasia - Fluoresceinvaatamisi: 30667 year old female with vision in only the left eye. She has mild CNVM which is treated with Avastin and does well over several years.aug 16, 2022
|
|
Stage V (neovascular) Macular Telangiectasia - Fluoresceinvaatamisi: 31867 year old female with vision in only the left eye. She has mild CNVM which is treated with Avastin and does well over several years.aug 16, 2022
|
|
Stage V (neovascular) Macular Telangiectasia - Fluoresceinvaatamisi: 31167 year old female with vision in only the left eye. She has mild CNVM which is treated with Avastin and does well over several years.aug 16, 2022
|
|
Stage V (neovascular) Macular Telangiectasia - Fluoresceinvaatamisi: 30267 year old female with vision in only the left eye. She has mild CNVM which is treated with Avastin and does well over several years.aug 16, 2022
|
|
Stage V (neovascular) Macular Telangiectasia - Fluoresceinvaatamisi: 29067 year old female with vision in only the left eye. She has mild CNVM which is treated with Avastin and does well over several years.aug 16, 2022
|
|
Stage V (neovascular) Macular Telangiectasia - Fluoresceinvaatamisi: 28167 year old female with vision in only the left eye. She has mild CNVM which is treated with Avastin and does well over several years.aug 16, 2022
|
|
Stage V (neovascular) Macular Telangiectasia - Fluoresceinvaatamisi: 27567 year old female with vision in only the left eye. She has mild CNVM which is treated with Avastin and does well over several years.aug 16, 2022
|
|
Stage V (neovascular) Macular Telangiectasia - Fluoresceinvaatamisi: 27367 year old female with vision in only the left eye. She has mild CNVM which is treated with Avastin and does well over several years.aug 16, 2022
|
|
Stage V (neovascular) Macular Telangiectasia - Fluoresceinvaatamisi: 30867 year old female with vision in only the left eye. She has mild CNVM which is treated with Avastin and does well over several years.aug 16, 2022
|
|
Stage V (neovascular) Macular Telangiectasia - Fluoresceinvaatamisi: 30367 year old female with vision in only the left eye. She has mild CNVM which is treated with Avastin and does well over several years.aug 16, 2022
|
|
Macular Telangiectasis (MacTel) Both Eye - Stage IV - Pigment Spotsvaatamisi: 30063 year old female with Type II DM x 4 years. Vision is 20/40 both eyes.aug 03, 2021
|
|
Macular Telangiectasis (MacTel) Both Eye - Stage IV - Pigment Spotsvaatamisi: 33363 year old female with Type II DM x 4 years. Vision is 20/40 both eyes.aug 03, 2021
|
|
Macular Telangiectasis (MacTel) Both Eye - Stage IV - Pigment Spotsvaatamisi: 35163 year old female with Type II DM x 4 years. Vision is 20/40 both eyes.aug 03, 2021
|
|
Macular Telangiectasis (MacTel) Both Eye - Stage IV - Pigment Spotsvaatamisi: 32363 year old female with Type II DM x 4 years. Vision is 20/40 both eyes.aug 03, 2021
|
|
Macular Telangiectasis (MacTel) Both Eye - Stage IV - Pigment Spotsvaatamisi: 32663 year old female with Type II DM x 4 years. Vision is 20/40 both eyes.aug 03, 2021
|
|
Macular Telangiectasis (MacTel) Both Eye - Stage IV - Pigment Spotsvaatamisi: 32063 year old female with Type II DM x 4 years. Vision is 20/40 both eyes.aug 03, 2021
|
|
Macular Telangiectasia (MacTel) and Pattern Dystrophyvaatamisi: 40771 year old man with diabetes for 5 years and blurred vision in the left eye. VA 20/25 OD, 20/50 OS. OCT OS shows MacTelmai 05, 2020
|
|
Macular Telangiectasia (MacTel) and Pattern Dystrophyvaatamisi: 42671 year old man with diabetes for 5 years and blurred vision in the left eye. VA 20/25 OD, 20/50 OS. OCT OS shows MacTelmai 05, 2020
|
|
Macular Telangiectasia (MacTel) and Pattern Dystrophyvaatamisi: 38771 year old man with diabetes for 5 years and blurred vision in the left eye. VA 20/25 OD, 20/50 OS. OCT OS shows MacTelmai 05, 2020
|
|
Macular Telangiectasia (MacTel) and Pattern Dystrophyvaatamisi: 42471 year old man with diabetes for 5 years and blurred vision in the left eye. VA 20/25 OD, 20/50 OS. OCT OS shows MacTelmai 05, 2020
|
|
Macular Telangiectasia (MacTel) and Pattern Dystrophyvaatamisi: 40771 year old man with diabetes for 5 years and blurred vision in the left eye. VA 20/25 OD, 20/50 OS. OCT OS shows MacTelmai 05, 2020
|
|
Macular Telangiectasia (MacTel) and Pattern Dystrophyvaatamisi: 40671 year old man with diabetes for 5 years and blurred vision in the left eye. VA 20/25 OD, 20/50 OS. OCT OS shows MacTelmai 05, 2020
|
|
Macular Telangiectasia (MacTel) and Pattern Dystrophyvaatamisi: 40871 year old man with diabetes for 5 years and blurred vision in the left eye. VA 20/25 OD, 20/50 OS. OCT OS shows MacTelmai 05, 2020
|
|
Macular Telangiectasia (MacTel) and Pattern Dystrophyvaatamisi: 40871 year old man with diabetes for 5 years and blurred vision in the left eye. VA 20/25 OD, 20/50 OS. OCT OS shows MacTelmai 05, 2020
|
|
Macular Telangiectasia (MacTel) and Pattern Dystrophyvaatamisi: 44971 year old man with diabetes for 5 years and blurred vision in the left eye. VA 20/25 OD, 20/50 OS. OCT OS shows MacTelmai 05, 2020
|
|
Macular Telangiectasia (MacTel) and Pattern Dystrophyvaatamisi: 41771 year old man with diabetes for 5 years and blurred vision in the left eye. VA 20/25 OD, 20/50 OS. OCT OS shows MacTelmai 05, 2020
|
|
Macular Telangiectasia (MacTel) and Pattern Dystrophyvaatamisi: 42771 year old man with diabetes for 5 years and blurred vision in the left eye. VA 20/25 OD, 20/50 OS. OCT OS shows MacTelmai 05, 2020
|
|
Macular Telangiectasia (MacTel) and Pattern Dystrophyvaatamisi: 39471 year old man with diabetes for 5 years and blurred vision in the left eye. VA 20/25 OD, 20/50 OS. OCT OS shows MacTelmai 05, 2020
|
|
Macular Telangiectasia (MacTel) and Pattern Dystrophyvaatamisi: 36571 year old man with diabetes for 5 years and blurred vision in the left eye. VA 20/25 OD, 20/50 OS. OCT OS shows MacTelmai 05, 2020
|
|
Macular Telangiectasia (MacTel) and Pattern Dystrophyvaatamisi: 38871 year old man with diabetes for 5 years and blurred vision in the left eye. VA 20/25 OD, 20/50 OS. OCT OS shows MacTelmai 05, 2020
|
|
Macular Telangiectasia (MacTel) and Pattern Dystrophyvaatamisi: 37371 year old man with diabetes for 5 years and blurred vision in the left eye. VA 20/25 OD, 20/50 OS. OCT OS shows MacTelmai 05, 2020
|
|
Macular Telangiectasia (MacTel) and Pattern Dystrophyvaatamisi: 36771 year old man with diabetes for 5 years and blurred vision in the left eye. VA 20/25 OD, 20/50 OS. OCT OS shows MacTelmai 05, 2020
|
|
Macular Telangiectasia (MacTel) and Pattern Dystrophyvaatamisi: 39671 year old man with diabetes for 5 years and blurred vision in the left eye. VA 20/25 OD, 20/50 OS. OCT OS shows MacTelmai 05, 2020
|
|
Macular Telangiectasia (MacTel) and Pattern Dystrophyvaatamisi: 36771 year old man with diabetes for 5 years and blurred vision in the left eye. VA 20/25 OD, 20/50 OS. OCT OS shows MacTelmai 05, 2020
|
|
Macular Telangiectasia (MacTel) and Pattern Dystrophyvaatamisi: 40771 year old man with diabetes for 5 years and blurred vision in the left eye. VA 20/25 OD, 20/50 OS. OCT OS shows MacTelmai 05, 2020
|
|
Macular Telangiectasia (MacTel) and Pattern Dystrophyvaatamisi: 36871 year old man with diabetes for 5 years and blurred vision in the left eye. VA 20/25 OD, 20/50 OS. OCT OS shows MacTelmai 05, 2020
|
|
Macular Telangiectasia (MacTel) and Pattern Dystrophyvaatamisi: 40771 year old man with diabetes for 5 years and blurred vision in the left eye. VA 20/25 OD, 20/50 OS. OCT OS shows MacTelmai 05, 2020
|
|
Macular Telangiectasia (MacTel) and Pattern Dystrophyvaatamisi: 40671 year old man with diabetes for 5 years and blurred vision in the left eye. VA 20/25 OD, 20/50 OS. OCT OS shows MacTelmai 05, 2020
|
|
Macular Telangiectasia (MacTel) and Pattern Dystrophyvaatamisi: 38271 year old man with diabetes for 5 years and blurred vision in the left eye. VA 20/25 OD, 20/50 OS. OCT OS shows MacTelmai 05, 2020
|
|
Macular Telangiectasia (MacTel) and Pattern Dystrophyvaatamisi: 40871 year old man with diabetes for 5 years and blurred vision in the left eye. VA 20/25 OD, 20/50 OS. OCT OS shows MacTelmai 05, 2020
|
|
Macular Telangiectasia (MacTel) and Pattern Dystrophyvaatamisi: 43271 year old man with diabetes for 5 years and blurred vision in the left eye. VA 20/25 OD, 20/50 OS. OCT OS shows MacTelmai 05, 2020
|
|
Macular Telangiectasia (MacTel) and Pattern Dystrophyvaatamisi: 39271 year old man with diabetes for 5 years and blurred vision in the left eye. VA 20/25 OD, 20/50 OS. OCT OS shows MacTelmai 05, 2020
|
|
Macular Telangiectasia (MacTel) and Pattern Dystrophyvaatamisi: 45371 year old man with diabetes for 5 years and blurred vision in the left eye. VA 20/25 OD, 20/50 OS. OCT OS shows MacTelmai 05, 2020
|
|
Macular Telangiectasia (MacTel) and Pattern Dystrophyvaatamisi: 51271 year old man with diabetes for 5 years and blurred vision in the left eye. VA 20/25 OD, 20/50 OS. OCT OS shows MacTelmai 05, 2020
|
|
vaatamisi: 384mai 04, 2020
|
|
vaatamisi: 381mai 04, 2020
|
|
vaatamisi: 362mai 04, 2020
|
|
vaatamisi: 388mai 04, 2020
|
|
vaatamisi: 389mai 04, 2020
|
|
vaatamisi: 373mai 04, 2020
|
|
vaatamisi: 397mai 04, 2020
|
|
vaatamisi: 381mai 04, 2020
|
|
| 433 faili 5 lehel |
1 |
 |
|
|
